GeoVax Awarded NIH Contract for up to $7.8 Million to Manufacture HIV Vaccine for Advanced Human Clinical Trials Life Science Investing
Shepard Vision, Inc., a Wholly-Owned Subsidiary of Nichi-Iko Pharmaceutical Co., Ltd, Commences All-Cash Tender Offer of $21.75 Net Per Share to Acquire All Outstanding Shares of Sagent Pharmaceuticals, Inc. Life Science Investing
Gilead’s Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) Meets Primary 48-Week Objective in Two Phase 3b Studies Life Science Investing
Inotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent Biotech Investing
Heat Biologics Announces Suspension of Proposed Public Offering of Common Stock Life Science Investing
Sunovion Announces Results of Phase 3 Long-Term Safety Study Showing SUN-101/eFlow® (glycopyrrolate) Was Well-Tolerated in People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD) Life Science Investing
DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology Annual Meeting in October 2016 Life Science Investing
SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc. Highlighting Recent Uplisting to Nasdaq Life Science Investing
